Literature DB >> 18444859

Treatment of joint prosthesis infection in accordance with current recommendations improves outcome.

Belinda Y Betsch1, Stefan Eggli, Klaus A Siebenrock, Martin G Täuber, Kathrin Mühlemann.   

Abstract

BACKGROUND: Recently recommended treatment modalities for prosthetic joint infection (PJI) were evaluated.
METHODS: A retrospective cohort analysis of 68 patients with PJI of hip or knee who were treated from 1995 through 2004 was conducted at the University Hospital Bern (Bern, Switzerland).
RESULTS: A 2-stage exchange was the most frequent (75.0%) surgical strategy, followed by retention and debridement (17.6%), 1-stage exchange (5.9%), and resection arthroplasty or suppressive antimicrobial treatment (1.5%). The chosen strategy was in 88% agreement with the recommendations. Adherence was only 17% for retention and debridement and was 0% for 1-stage exchange. Most PJIs (84%) were treated with an adequate or partially adequate antimicrobial regimen. Recurrence-free survival was observed in 51.5% of PJI episodes after 24 months of follow-up. The risk of treatment failure was significantly higher for PJI treated with a surgical strategy other than that recommended (hazard ratio, 2.34; 95% confidence interval, 1.10-4.70; P = .01) and for PJIs treated with antibiotics not corresponding to recommendations (hazard ratio, 3.45; confidence interval, 1.50-7.60; P = .002). Other risk factors associated with lack of healing were a high infection score at the time of diagnosis (hazard ratio, 1.29; 95% confidence interval, 1.10-1.40; P < .001) and presence of a sinus tract (hazard ratio, 2.35; 95% confidence interval, 1.10-5.0; P = .02).
CONCLUSIONS: Our study demonstrates the value of current treatment recommendations. Inappropriate choice of conservative surgical strategies (such as debridement and retention) and inadequate antibiotic treatment are associated with failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18444859     DOI: 10.1086/529436

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Risk factors and a prognostic model of hip periprosthetic infection recurrence after surgical treatment using articulating and non-articulating spacers.

Authors:  Rashid Tikhilov; Svetlana Bozhkova; Alexey Denisov; Dmitry Labutin; Igor Shubnyakov; Vadim Razorenov; Vasilii Artyukh; Olga Klitsenko
Journal:  Int Orthop       Date:  2015-12-19       Impact factor: 3.075

2.  Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection.

Authors:  T Ferry; I Uçkay; P Vaudaux; P François; J Schrenzel; S Harbarth; F Laurent; L Bernard; F Vandenesch; J Etienne; P Hoffmeyer; D Lew
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-28       Impact factor: 3.267

3.  Baseline hypovitaminosis D is not associated with poor clinical outcomes in osteoarticular infections.

Authors:  J Marschall; J W S Lewis; D K Warren; H M Babcock; R L Barrack; V J Fraser
Journal:  Int J Infect Dis       Date:  2014-07-12       Impact factor: 3.623

4.  Characteristics and treatment outcomes of 69 cases with early prosthetic joint infections of the hip and knee.

Authors:  Y Achermann; P Stasch; S Preiss; K Lucke; M Vogt
Journal:  Infection       Date:  2014-01-29       Impact factor: 3.553

Review 5.  Is prosthesis retention effective for chronic infections in hip arthroplasties? A systematic literature review.

Authors:  M Maillet; P Pavese; D Bruley; A Seigneurin; P François
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-30       Impact factor: 3.267

6.  A Multicenter Study of Irrigation and Debridement in Total Knee Arthroplasty Periprosthetic Joint Infection: Treatment Failure Is High.

Authors:  Kenneth L Urish; Andrew G Bullock; Alexander M Kreger; Neel B Shah; Kwonho Jeong; Scott D Rothenberger
Journal:  J Arthroplasty       Date:  2017-11-21       Impact factor: 4.757

7.  High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.

Authors:  Raluca Mihailescu; Ulrika Furustrand Tafin; Stéphane Corvec; Alessandra Oliva; Bertrand Betrisey; Oliver Borens; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

8.  Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey.

Authors:  Jonas Marschall; Michael A Lane; Susan E Beekmann; Philip M Polgreen; Hilary M Babcock
Journal:  Int J Antimicrob Agents       Date:  2013-01-09       Impact factor: 5.283

Review 9.  Clinical practice. Infection associated with prosthetic joints.

Authors:  Jose L Del Pozo; Robin Patel
Journal:  N Engl J Med       Date:  2009-08-20       Impact factor: 91.245

10.  Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis.

Authors:  Andrej Trampuz; Werner Zimmerli
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.